Sorting nexin 3 induces heart failure via promoting retromer-dependent nuclear trafficking of STAT3

• Published in: Cell death and differentiation 2021-10, Vol.28 (10), p.2871-2887
• Main Authors: Lu, Jing, Xu, Suowen, Huo, Yuqing, Sun, Duanping, Hu, Yuehuai, Wang, Junjian, Zhang, Xiaolei, Wang, Panxia, Li, Zhuoming, Liang, Mengya, Wu, Zhongkai, Liu, Peiqing
• Format: Article
• Language: English
• Subjects: 13; 13/89; 14/19; 14/5; 38/77; 42/44; 631/337; 64/110; 64/60; 692/699/75; 82/103; 82/51; 82/58; 82/80; 82/83; 96/109; 96/34; 96/95; Animals; Apoptosis; Biochemistry; Biomedical and Life Sciences; Cardiomyocytes; Cardiovascular diseases; Cell Biology; Cell Cycle Analysis; Cell Nucleus - metabolism; Congestive heart failure; Coronary artery disease; Disease Models, Animal; Echocardiography; Fibrosis; Glycoprotein gp130; Heart failure; Heart Failure - metabolism; Humans; Hypertrophy; Immunoprecipitation; Isoproterenol; Janus kinase 2; Life Sciences; Mass spectroscopy; Mice; Mice, Inbred C57BL; Mice, Knockout; Nexin; Phosphorylation; Signal Transduction; Sorting Nexins - metabolism; Stat3 protein; STAT3 Transcription Factor - metabolism; Stem Cells; Surface plasmon resonance; Therapeutic targets; Transcription; Transgenic mice; Up-Regulation
• ISSN: 1350-9047; 1476-5403
• DOI: 10.1038/s41418-021-00789-w

Sorting nexins (SNXs), the retromer-associated cargo binding proteins, have emerged as critical regulators of the trafficking of proteins involved in the pathogenesis of diverse diseases. However, studies of SNXs in the development of cardiovascular diseases, especially cardiac hypertrophy and heart failure, are lacking. Here, we ask whether SNX3, the simplest structured isoform in the SNXs family, may act as a key inducer of myocardial injury. An increased level of SNX3 was observed in failing hearts from human patients and mice. Cardiac-specific Snx3 knockout ( Snx3-cKO ) mice and Snx3 transgenic ( Snx3-cTg ) mice were generated to evaluate the role of Snx3 in myocardial hypertrophy, fibrosis, and heart function by morphology, echocardiography, histological staining, and hypertrophic biomarkers. We report that Snx3-cKO in mice significantly protected against isoproterenol (ISO)-induced cardiac hypertrophy at 12 weeks. Conversely, Snx3-cTg mice were more susceptible to ISO-induced cardiac hypertrophy at 12 weeks and showed aggravated cardiac injury even heart failure at 24 weeks. Immunoprecipitation-based mass spectrometry, immunofluorescent staining, co-immunoprecipitation, localized surface plasmon resonance, and proximity ligation assay were performed to examine the direct interaction of SNX3-retromer with signal transducer and activator of transcription 3 (STAT3). We discovered that STAT3 was a new interacting partner of SNX3-retromer, and SNX3-retromer served as an essential platform for assembling gp130/JAK2/STAT3 complexes and subsequent phosphorylation of STAT3 by direct combination at EE. SNX3-retromer and STAT3 complexes were transiently imported into the nucleus after hypertrophic stimuli. The pharmacological inhibition or knockdown of STAT3 reversed SNX3 overexpression-induced myocardial injury. STAT3 overexpression blunts the beneficial function of SNX3 knockdown on hypertrophic cardiomyocytes. We show that SNX3-retromer promoted importin α3-mediated STAT3 nuclear trafficking and ultimately leading to cardiac injury. Taken together, our study reveals that SNX3 plays a key role in cardiac function and implicates SNX3 as a potential therapeutic target for cardiac hypertrophy and heart failure.